# Sanoculis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sanoculis

- Industry: Medical Devices & Equipment
- Headquarters: Kiryat Ono, Israel
- Website: www.sanoculis.com
- Latest round: Series C (Jan 25, 2023)
- Investors on record: 2

## About

Based in Kiryat Ono, Israel, and founded in 2012 by co-founder and CEO Nir Israeli, and Vadim Shmukler, Sanoculis Ltd., a.k.a. Sanoculis operates as an ophthalmic medical equipment company that manufactures devices for the treatment of eye diseases, particularly the minimally invasive micro sclerotomy for glaucoma. In January 2023, Sanoculis Ltd. raised a Series C funding from Eckuity and Bausch & Lomb Optical Company.

The company’s product line includes MIMS, a lightweight surgical system intended for use by professional ophthalmologists that creates a drainage channel to reduce IOP in glaucoma patients, ensuring a long-lasting safe, and controlled fluid flow, no stitches, eye-patch, implant, or stent.

Sanoculis plans to use its proceeds from January 2023 funding to expand its business and customer base in Europe.

## Funding rounds

- Series C, Jan 25, 2023 — Bausch + Lomb Corporation, Eckuity Capital

## Investors

- Bausch + Lomb Corporation — Series C
- Eckuity Capital (https://capitalatlas.ai/funds/eckuity-capital) — Series C